Vontobel Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Vontobel Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-308,640	Closed	-$16.8M	–	67
2017 Q1	$16.8M	Sell	308,640 -2,023,235	-87%	-$111M	0.14%	47
2016 Q4	$141M	Sell	2,331,875 -105,561	-4%	-$5.77M	1.24%	31
2016 Q3	$136M	Buy	2,437,436 +531,636	+28%	+$34.1M	1.06%	35
2016 Q2	$146M	Sell	1,905,800 -905,279	-32%	-$64M	1.19%	35
2016 Q1	$186M	Buy	2,811,079 +243,573	+9%	+$15.4M	1.44%	30
2015 Q4	$186M	Sell	2,567,506 -491,182	-16%	-$32.5M	1.44%	25
2015 Q3	$193M	Sell	3,058,688 -45,701	-1%	-$2.9M	1.64%	23
2015 Q2	$216M	Sell	3,104,389 -61,805	-2%	-$4.07M	1.64%	16
2015 Q1	$213M	Buy	3,166,194 +57,977	+2%	+$3.63M	1.61%	20
2014 Q4	$188M	Buy	3,108,217 +1,122,162	+57%	+$63.3M	1.54%	22
2014 Q3	$104M	Buy	+1,986,055	New	+$99.2M	0.81%	35

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vontobel Asset Management's BMY Position: Q2 2017 in Review

Vontobel Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 308,640 shares — an estimated $16.8M sold.

Vontobel Asset Management first reported a position in BMY in Q3 2014 and held it in 11 quarters. The position peaked at $216M in Q2 2015. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Vontobel Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
Vontobel Asset Management sold 308,640 Bristol-Myers Squibb shares in Q2 2017, an estimated $16.8M.
Vontobel Asset Management first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 11 quarters.
Vontobel Asset Management's Bristol-Myers Squibb position peaked at $216M in Q2 2015.
1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Vontobel Asset Management's 13F filing for Q2 2017, filed 12 Jul 2017.